Oncolytic Herpes Simplex Virus Encoding IL12 Controls Triple-Negative Breast Cancer Growth and Metastasis
Author:
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference50 articles.
1. Recent advances in nanotheranostics for triple negative breast cancer treatment;Thakur;J Exp Clin Cancer Res.,2019
2. Triple-negative breast cancers: systematic review of the literature on molecular and clinical features with a focus on treatment with innovative drugs;Diana;Curr Oncol Rep.,2018
3. Insights into molecular classifications of triple-negative breast cancer: improving patient selection for treatment;Garrido-Castro;Cancer Discov.,2019
4. Breast cancer treatment: a review;Waks;JAMA.,2019
5. Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state;Echeverria;Sci Transl Med.,2019
Cited by 53 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Antimetastatic and antitumor activities of oncolytic NDV AMHA1 in a 3D culture model of breast cancer;Frontiers in Molecular Biosciences;2024-08-30
2. Targeting cytokine and chemokine signaling pathways for cancer therapy;Signal Transduction and Targeted Therapy;2024-07-22
3. Simultaneous Expression of Different Therapeutic Genes by Infection with Multiple Oncolytic HSV-1 Vectors;Biomedicines;2024-07-16
4. Oncolytic herpes simplex virus expressing IL-2 controls glioblastoma growth and improves survival;Journal for ImmunoTherapy of Cancer;2024-04
5. Immune landscape and response to oncolytic virus-based immunotherapy;Frontiers of Medicine;2024-03-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3